A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 158 participants.

Also called NCT02156076

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose other
Phase
Phase 2
Enrolled
  • 158 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02156076
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02156076. Randomized; quadruple masking; primary purpose other. Start 2014-07-25 (actual); primary completion 2016-06-01 (actual). Results posted on 2019-05-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
Condition
Paroxysmal Atrial Fibrillation
Intervention (Drug)
BMS-919373
Intervention (Drug)
Placebo (Matching with BMS-919373)
Lead sponsor
Bristol-Myers Squibb (class: industry)

Record details

Record id
cardio:ct-nct02156076
Content hash
2e51c267d7ea8c2b34b93293bf2b91cca06ea72726026d6cd518b7d25d1d04fb